Literature DB >> 15540222

Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1).

Stefan Nagel1, Maren Kaufmann, Michaela Scherr, Hans G Drexler, Roderick A F MacLeod.   

Abstract

Mutation or dysregulation of related homeobox genes occurs in leukemia. Using RT-PCR, we screened members of the EHG family of homeobox genes, comprising EN1 (at 2q14), GBX2 (at 2q36), and EN2, GBX1, and HLXB9 (at 7q36), for dysregulation in acute myeloid leukemia (AML) cell lines indicated by chromosomal breakpoints at these sites. Only one EHG-family gene was expressed, HLXB9, in cell line GDM-1 (AML-M4). Karyotypic analysis of GDM-1 revealed a unique t(6;7)(q23;q35), also present in the patient. Fluorescence in situ hybridization analysis showed chromosomal breakpoints close to the region upstream of HLXB9, at 7q36, a region rearranged in certain AML patients, and at 6q23 upstream of MYB, a gene activated in leukemia. Detailed expression analysis suggested ectopic activation of HLXB9 occurred via juxtaposition with regions upstream of MYB, which was highly expressed in GDM-1. Our data identified a cell line model for a novel leukemic translocation involving MYB with HLXB9, further implicating HLXB9 in leukemogenesis. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15540222     DOI: 10.1002/gcc.20113

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  13 in total

1.  The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators.

Authors:  Kerong Shi; Vaishali I Parekh; Swarnava Roy; Shruti S Desai; Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2013-02-18       Impact factor: 5.678

2.  Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.

Authors:  Yoshitsugu Mitani; Pulivarthi H Rao; P Andrew Futreal; Dianna B Roberts; Philip J Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S Weber; Scott M Lippman; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2011-10-05       Impact factor: 12.531

3.  Homeobox protein HB9 binds to the prostaglandin E receptor 2 promoter and inhibits intracellular cAMP mobilization in leukemic cells.

Authors:  Sarah Wildenhain; Deborah Ingenhag; Christian Ruckert; Özer Degistirici; Martin Dugas; Roland Meisel; Julia Hauer; Arndt Borkhardt
Journal:  J Biol Chem       Date:  2012-10-08       Impact factor: 5.157

4.  Novel insights into the role of aberrantly expressed MNX1 (HLXB9) in infant acute myeloid leukemia.

Authors:  Juerg Schwaller
Journal:  Haematologica       Date:  2019-01       Impact factor: 9.941

5.  Oncogenic role of engrailed-2 (en-2) in prostate cancer cell growth and survival.

Authors:  Sudeep K Bose; Rebecca S Bullard; Carlton D Donald
Journal:  Transl Oncogenomics       Date:  2008-03-03

6.  Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.

Authors:  Peter C Scacheri; Sean Davis; Duncan T Odom; Gregory E Crawford; Stacie Perkins; Mohamad J Halawi; Sunita K Agarwal; Stephen J Marx; Allen M Spiegel; Paul S Meltzer; Francis S Collins
Journal:  PLoS Genet       Date:  2006-04-07       Impact factor: 5.917

7.  HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-BE neuroblastoma cell line.

Authors:  Claudia Giovanna Leotta; Concetta Federico; Maria Violetta Brundo; Sabrina Tosi; Salvatore Saccone
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

8.  Comparative Analysis of Prostate Cancer Gene Regulatory Networks via Hub Type Variation.

Authors:  Pegah Khosravi; Vahid H Gazestani; Mohammad Akbarzadeh; Samira Mirkhalaf; Mehdi Sadeghi; Bahram Goliaei
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jan-Mar

Review 9.  Paediatric acute myeloid leukaemia with the t(7;12)(q36;p13) rearrangement: a review of the biological and clinical management aspects.

Authors:  Sabrina Tosi; Yasser Mostafa Kamel; Temitayo Owoka; Concetta Federico; Tony H Truong; Salvatore Saccone
Journal:  Biomark Res       Date:  2015-10-05

10.  Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.

Authors:  Mingkun Chen; Rongpei Wu; Gang Li; Cundong Liu; Lei Tan; Kanghua Xiao; Yunlin Ye; Zike Qin
Journal:  J Exp Clin Cancer Res       Date:  2018-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.